Australia markets close in 3 hours 7 minutes

Vaccinex, Inc. (VCNX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
6.00-0.50 (-7.69%)
At close: 04:00PM EDT
7.50 +1.50 (+25.00%)
After hours: 07:57PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
50
570
275
900
50
Cost of revenue
-
-
-
0
2
Gross profit
-
-
-
900
48
Operating expenses
Research development
14,192
16,574
13,979
17,160
21,549
Selling general and administrative
6,163
6,881
6,202
6,230
7,405
Total operating expenses
20,355
23,455
20,181
23,390
28,379
Operating income or loss
-20,305
-22,885
-19,906
-22,490
-28,331
Interest expense
-14
1
2
809
489
Total other income/expenses net
923
2,635
93
919
-31
Income before tax
-19,368
-20,251
-19,815
-22,380
-28,851
Income tax expense
0
0
0
0
0
Income from continuing operations
-19,368
-20,251
-19,815
-22,380
-28,851
Net income
-19,368
-20,251
-19,815
-22,380
-28,851
Net income available to common shareholders
-19,368
-20,251
-19,815
-22,380
-28,851
Basic EPS
-83.86
-
-98.05
-163.80
-323.40
Diluted EPS
-83.86
-
-98.05
-163.80
-323.40
Basic average shares
266.151
-
202.082
137.377
89.46
Diluted average shares
266.151
-
202.082
137.377
89.46